Literature DB >> 6187684

Serological, chemical, and structural analyses of the Escherichia coli cross-reactive capsular polysaccharides K13, K20, and K23.

W F Vann, T Soderstrom, W Egan, F P Tsui, R Schneerson, I Orskov, F Orskov.   

Abstract

The Escherichia coli K13, K20, and K23 capsular polysaccharide antigens are serologically related. All of these polysaccharides contain ribose and 2-keto-3-deoxyoctonate in equimolar quantities. The K13 and K20 polysaccharides are partially O-acetylated. A comparison of these polysaccharides after O-deacetylation, by nuclear magnetic resonance and permethylation analysis, showed that these polysaccharides contained the disaccharide repeat unit leads to)-beta-ribofuranosyl-(1 leads to 7)-beta-2-keto-3-deoxyoctonate. They differed in the presence and location of an acetyl moiety. The K13 polysaccharide was O-acetylated at C-4 of the 2-keto-3-deoxyoctonate. The K20 antigen was O-acetylated at C-5 of the ribose moiety. The K23 polymer was nonacetylated. The cross-reactivity of these antigens was demonstrated by tandem-crossed immunoelectrophoresis. Antibodies to K23 could be completely absorbed from OK K23 serum by K13, K20, and K23 antigenic extracts. The K13 and K20 antibodies could be completely absorbed from their respective antisera only by homologous antigenic extracts. Monoclonal antibodies were prepared against a protein conjugate of the K13 polysaccharide. Analyses of the reactions of these antibodies with the three polysaccharides suggest that the K13 polysaccharide has at least three antigenic sites, one of which is common to the K13, K20, and K23 polysaccharides.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187684      PMCID: PMC347997          DOI: 10.1128/iai.39.2.623-629.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

Review 2.  Serology, chemistry, and genetics of O and K antigens of Escherichia coli.

Authors:  I Orskov; F Orskov; B Jann; K Jann
Journal:  Bacteriol Rev       Date:  1977-09

3.  A manual of quantitative immunoelectrophoresis. Methods and applications. 1. General remarks on principles, equipment, reagents and procedures.

Authors:  B Weeke
Journal:  Scand J Immunol Suppl       Date:  1973

4.  Crossed immunoelectrophoresis.

Authors:  B Weeke
Journal:  Scand J Immunol Suppl       Date:  1973

5.  Intermediate gel in crossed and in fused rocket immunoelectrophoresis.

Authors:  N H Axelsen
Journal:  Scand J Immunol Suppl       Date:  1973

6.  Tandem-crossed immunoelectrophoresis.

Authors:  J Kroll
Journal:  Scand J Immunol Suppl       Date:  1973

7.  Comparison of antigens: the reaction of 'identity'.

Authors:  N H Axelsen; E Bock; J Kroll
Journal:  Scand J Immunol Suppl       Date:  1973

8.  Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children.

Authors:  F Orskov; I Orskov; D J Evans; R B Sack; D A Sack; T Wadström
Journal:  Med Microbiol Immunol       Date:  1976-06-01       Impact factor: 3.402

9.  Structural elucidation of the 3-deoxy-D-manno-octulosonic acid containing meningococcal 29-e capsular polysaccharide antigen using carbon-13 nuclear magnetic resonance.

Authors:  A K Bhattacharjee; H J Jennings; C P Kenny
Journal:  Biochemistry       Date:  1978-02-21       Impact factor: 3.162

10.  Frequency of E. coli K antigens in urinary-tract infections in children.

Authors:  B Kaijser; L A Hanson; U Jodal; G Lidin-Janson; J B Robbins
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

View more
  9 in total

1.  Differential occurrence of Streptococcus pneumoniae serotype 11E between asymptomatic carriage and invasive pneumococcal disease isolates reflects a unique model of pathogen microevolution.

Authors:  Juan J Calix; Ron Dagan; Stephen I Pelton; Nurith Porat; Moon H Nahm
Journal:  Clin Infect Dis       Date:  2012-01-19       Impact factor: 9.079

2.  Detection of Escherichia coli K95 strains by bacteriophages.

Authors:  W Nimmich
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

3.  Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.

Authors:  T Söderström; L Ohman; K Stein; R Schneerson; W F Vann; L A Hanson
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

4.  Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide.

Authors:  J M Fournier; W F Vann; W W Karakawa
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

5.  Relation between structure and immunologic properties of the Vi capsular polysaccharide.

Authors:  S C Szu; X R Li; A L Stone; J B Robbins
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

6.  Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.

Authors:  T Söderström; L Ohman; K Stein; R Schneerson; W F Vann; L A Hanson
Journal:  Infection       Date:  1985       Impact factor: 3.553

7.  Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice.

Authors:  K E Stein; T Söderström
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

8.  Identification of Streptococcus pneumoniae serotype 11E, serovariant 11Av and mixed populations by high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and flow cytometric serotyping assay (FCSA).

Authors:  Romina Camilli; Brady L Spencer; Monica Moschioni; Vittoria Pinto; Francesco Berti; Moon H Nahm; Annalisa Pantosti
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

9.  Chemical structure and genetic organization of the E. coli O6:K15 capsular polysaccharide.

Authors:  Hugo F Azurmendi; Vamsee Veeramachineni; Stephen Freese; Flora Lichaa; Darón I Freedberg; Willie F Vann
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.